World Health Organization. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge, New York: Cambridge University Press 1993.
Nickel JC. Classification and diagnosis of prostatitis: a gold standard? Andrologia 2003, 35: 160–7.
Weidner W, Krause W, Ludwig M. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update 1999, 5: 421–32.
Vicari E. Seminal leukocyte concentration and related specific reactive oxygen species production in patients with male accessory gland infections. Hum Reprod 1999, 14: 2025–30.
Schill WB, Henkel R. Advancement in biochemical assays in andrology. Asian J Androl 1999, 1: 45–51.
World Health Organization. WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction, 4th ed. Cambridge, UK: Cambridge University Press 1999.
Gonzales GF, Villena A. True corrected seminal fructose level: a better marker of the function of seminal vesicle in infertile men. Int J Androl 2001, 24: 255–60.
Vicari E. Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection. Hum Reprod 2000, 15: 2536–44.
Cohen J, Edwards R, Fehilly C, et al. In vitro fertilization: a treatment for male infertility. Fertil Steril 1985, 43: 422–32.
Phadke AM. Neutral red supravital staining for cellular elements in the semen. Andrologia 1978, 10: 80–4.
Mann T, Lutwak-Mann C. Evaluation of the functional state of male accessory glands by the analysis of seminal plasma. Andrologia 1976, 8: 237–42.
Purvis K, Christiansen E. Infection in the male reproductive tract. Impact, diagnosis and treatment in relation to male infertility. Int J Androl 1993, 16: 1–13.
Kim ED, Lipschultz LI. Role of ultrasound in the assessment of male infertility. J Clin Ultrasound 1996, 24: 437–53.
Schipper RA, Trum JW, Messelink EJ, van der Veen F, Kurth KH. Transrectal ultrasonography in male subfertility patients: an intra- and interobserver study. Urol Res 2001, 29: 57–9.
Furuya R, Takahashi S, Furuya S, Kunishima Y, Takeyama K, Tsukamoto T. Is seminal vesiculitis a discrete disease entity? Clinical and microbiological study of seminal vesiculitis in patients with acute epididymitis. J Urol 2004, 171: 1550–3.
Vicari E, La Vignera S, Calogero AE. Antioxidant treatment with carnitines is effective in infertile patients with prostato-vesciculo-epididymitis and elevated seminal leukocyte concentration after treatment with non-steroidal anti-inflammatory compounds. Fertil Steril 2002, 78: 1203–8.
Comhaire FH, Mahmoud AM, Depuydt CE, Zalata AA, Christophe AB. Mechanisms and effects of male genital tract infection on sperm quality and fertilized potential: the andrologist’s viewpoint. Hum Reprod Update 1999, 5: 393–8.
Pasqualotto FF, Sharma RK, Potts JM, Nelson DR, Thomas AJ, Agarwal A. Seminal oxidative stress in patients with chronic prostatitis. Urology 2000, 55: 881–5.
Gonzales G F. Function of seminal vesicles and their role on male fertility. Asian J Androl 2001, 3: 251–8.
Wang A, Fanning L, Anderson DJ, Loughlin KR. Generation of reactive oxygen species by leukocytes and sperm following exposure to urogenital tract infection. Arch Androl 1997, 39: 11–7.
Vicari E, Calogero AE. Effect of treatment with carnitines in patients with prostato-vesiculo-epididymitis. Hum Reprod 2001, 16: 2338–42.
Ochsendorf FR. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update 1999, 5: 399–420.
Gonzales G F, Kortebani G, Mazzolli AB. Leukocytospermia and function of the seminal vesicles on seminal quality. Fertil Steril 1992, 57: 1058–65.
Potts RJ, Jefferies TM, Notarianni LJ. Antioxidant capacity of the epididymis. Hum Reprod 1999, 14: 2513–6.